domains / families / science / hrd-analysis-agent

hrd-analysis-agent

separate

AI-powered homologous recombination deficiency (HRD) analysis for PARP inhibitor response prediction using genomic scarring signatures and BRCA pathway assessment.

When to use

• When determining HRD status for PARP inhibitor eligibility.
• To calculate genomic instability scores (GIS) from tumor sequencing.
• For analyzing BRCA1/2 and HRD gene mutations.
• When predicting response to PARP inhibitors or platinum chemotherapy.
• To identify "BRCAness" phenotype in BRCA wild-type tumors.

Skill page

Source